Aging complicates the management of von Willebrand disease due to changing VWF levels, increased cardiovascular risk, and specific bleeding challenges.
No takes yet. Share an insight, caveat, or question.
May inform individualized antithrombotic decisions in older VWD patients; hypothesis-generating for age-stratified VWF thresholds in prospective studies.
Barbara A. Konkle (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: